His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation.

Naturally occurring variation within the human 5-HT(2A) receptor results in an amino acid substitution in the carboxyl terminus of the receptor. This single nucleotide polymorphism (SNP), encoding a His452Tyr substitution, occurs at a frequency of 9% in the general population. It is noteworthy that this SNP has been linked to attention deficit hyperactivity disorder and has been associated with schizophrenic patients that do not respond to treatment with clozapine. To evaluate functional consequences of this SNP, agonist-stimulated signaling was investigated in NIH3T3 cells stably expressing either wild-type or 452Tyr variant receptors. The 452Tyr variant of the 5-HT(2a) receptor had reduced ability to activate phospholipases C and D, suggesting that signaling through both G(q) and G(13) pathways is hindered. This conclusion was supported by assays of G protein coupling, which documented a loss of agonist-induced high affinity binding and a decreased turnover of guanosine 5'-O-(3-[(35)S]thio)triphosphate after agonist stimulation. Kinetic analysis of time-course data revealed an altered desensitization phenotype, resulting in a blunted signal downstream of receptor activation. This diminished signaling implies that the His452Tyr variant receptor alters physiological responses, possibly contributing to psychiatric disease.

[1]  D. Collier,et al.  Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine , 1998, Molecular Psychiatry.

[2]  E. sanders-Bush,et al.  Generation of anti-peptide antibodies against serotonin 5-HT2A and 5-HT2C receptors , 1997, Journal of Neuroscience Methods.

[3]  M. J. Arranz,et al.  Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response , 1998, Schizophrenia Research.

[4]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[5]  M. J. Arranz,et al.  Association between clozapine response and allelic variation in 5-HT2A receptor gene , 1995, The Lancet.

[6]  L. Descarries,et al.  Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat , 1999, The Journal of comparative neurology.

[7]  M. Gill,et al.  European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. , 1998, American journal of medical genetics.

[8]  S. Maayani,et al.  Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation. , 2001, The Journal of pharmacology and experimental therapeutics.

[9]  P. Conn,et al.  Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  J. Wess,et al.  Functional characterization of five V2 vasopressin receptor gene mutations , 1996, Molecular and Cellular Endocrinology.

[11]  H. Manji,et al.  A Naturally Occurring Amino Acid Substitution of the Human Serotonin 5‐HT2A Receptor Influences Amplitude and Timing of Intracellular Calcium Mobilization , 1997, Journal of neurochemistry.

[12]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[13]  E. sanders-Bush,et al.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. , 1994, The Journal of biological chemistry.

[14]  M. Grotewiel,et al.  Regulation of Serotonin2A Receptors in Heterologous Expression Systems , 1994, Journal of neurochemistry.

[15]  M. Rietschel,et al.  Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia , 1996, Human Genetics.

[16]  V. Arango,et al.  In vitro autoradiography of serotonin 5‐HT2A/2C receptor‐activated G protein: Guanosine‐5′‐(γ‐[35S]thio)triphosphate binding in rat brain , 2000, Journal of neuroscience research.

[17]  P. Zwanzger,et al.  Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression , 2001, European Neuropsychopharmacology.

[18]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[19]  B. Roth,et al.  5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. , 1995, The Journal of pharmacology and experimental therapeutics.

[20]  M. Millan,et al.  Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. , 2002, Molecular pharmacology.

[21]  W. Roberts,et al.  Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD) , 2000, Molecular Psychiatry.

[22]  B. Roth,et al.  Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. , 1998, Critical reviews in neurobiology.

[23]  E. sanders-Bush,et al.  Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits. , 2002, Molecular pharmacology.

[24]  R. Lefkowitz,et al.  Desensitization of G protein-coupled receptors. , 1996, Recent progress in hormone research.

[25]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[26]  J. Fink,et al.  An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. , 1992, Human molecular genetics.

[27]  U. Pesonen,et al.  Two naturally occurring amino acid substitutions of the 5-HT2A receptor: Similar prevalence in patients with seasonal affective disorder and controls , 1996, Biological Psychiatry.

[28]  Jeffrey A Lieberman,et al.  Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients , 1998, Neuropsychopharmacology.

[29]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.